SYNUCLERE

Welcome to the Brand page for “SYNUCLERE”, which is offered here for Pharmaceutical preparations for the prevention of synucleinopathies including lewy body disease and parkinson's disease; pharmaceutical preparations for the treatment of synucleinopathies including lewy body disease and parkinson's disease;.

Its status is currently believed to be active. Its class is unavailable. “SYNUCLERE” is believed to be currently owned by “ProtaMed, Inc.”